Olverembatinib for FGFR1-rearranged Neoplasms

Clinical trial NCT05521204 · RECRUITING

Trial details

NCT number: NCT05521204
Sponsor: The First Affiliated Hospital of Soochow University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myeloproliferative Neoplasm Acute Leukemia

Start date: 2022-09-01
Primary completion: 2024-08-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.